PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent...

por Dillon, M.T., Boylan, Z., Smith, D., Guevara, J., Mohammed, K., Peckitt, C., Saunders, M., Banerji, U., Clack, G., Smith, S.A., Spicer, J.F., Forster, M.D., Harrington, K.J.
Publicado 2018

OX40 and 4-1BB delineate distinct immune profiles in sarcoma

por Melake, MJ, Smith, HG, Mansfield, D, Davies, E, Dillon, MT, Wilkins, AC, Patin, EC, Pedersen, M, Buus, R, Melcher, AA, Thway, K, Miah, AB, Zaidi, SH, Hayes, AJ, Fenton, TR, Harrington, KJ, McLaughlin, M
Publicado 2022